StockData

Cosmos Health vs Hydrofarm

COSM and HYFM side by side, both in wholesale trade-non-durable goods. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How COSM and HYFM compare

Cosmos Health is the larger company, worth 88 times as much as Hydrofarm ($287M against $3.3M).

Cosmos Health grew revenue faster over the last twelve months (33.8% versus −34.1% for Hydrofarm).

Cosmos Health keeps more of each dollar of sales as profit, with a net margin of −33.1% compared with −267% at Hydrofarm.

Cosmos Health scores higher on the StockData Score (4 against 1 for Hydrofarm), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricCOSMHYFM
Size and price
Market cap$287M$3.3M
Share price$2.85$0.680
Change, 1 year295%−61.8%
Change, 5 years−99.8%−99.8%
Beta (5Y)–5.55
Employees163251
StockData Score
Total score4 (better)1
Valuation score01 (better)
Growth score2 (better)0
Performance score00
Health score2 (better)0
Dividend score00
Valuation
P/S3.9×0.0× (better)
P/B13.9×–
FCF yield−3.5% (better)−162%
Fair value$1.38–
Margin of safety−107%–
Growth
Revenue growth (TTM)33.8% (better)−34.1%
Revenue growth, 5Y average3.3% (better)−17.1%
Profitability
Gross margin10.3% (better)9.4%
Operating margin−24.9% (better)−253%
Net margin−33.1% (better)−267%
FCF margin−13.5%−5.0% (better)
Return on equity−104% (better)−536%
Return on invested capital−60.9% (better)−135%
Financial health
Debt / equity0.06–
Interest coverage−7.8× (better)−16.8×
Current ratio1.05 (better)0.27
Altman Z-score1.23 (better)−20.98
Piotroski F-score5 (better)2
Dividends and buybacks
Buyback yield−2.9%–
Shareholder yield−2.9%0.00% (better)
Ownership
Held by institutions2.1%6.3%
Held by insiders17.4%26.5%
Insider net buying, 12 months$1.6M (better)$12.6K
Short interest, % of float2.1%14.5%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.